Cargando…

Intranasal plus subcutaneous prime vaccination with a dual antigen COVID-19 vaccine elicits T-cell and antibody responses in mice

We have developed a COVID-19 vaccine, hAd5 S-Fusion + N-ETSD, that expresses SARS-CoV-2 spike (S) and nucleocapsid (N) proteins with modifications to increase immune responses delivered using a human adenovirus serotype 5 (hAd5) platform. Here, we demonstrate subcutaneous (SC) prime and SC boost vac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rice, Adrian, Verma, Mohit, Shin, Annie, Zakin, Lise, Sieling, Peter, Tanaka, Shiho, Balint, Joseph, Dinkins, Kyle, Adisetiyo, Helty, Morimoto, Brett, Higashide, Wendy, Anders Olson, C., Mody, Shivani, Spilman, Patricia, Gabitzsch, Elizabeth, Safrit, Jeffrey T., Rabizadeh, Shahrooz, Niazi, Kayvan, Soon-Shiong, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295250/ https://www.ncbi.nlm.nih.gov/pubmed/34290317 http://dx.doi.org/10.1038/s41598-021-94364-5

Ejemplares similares

Dual-Antigen COVID-19 Vaccine Subcutaneous Prime Delivery With Oral Boosts Protects NHP Against SARS-CoV-2 Challenge
por: Gabitzsch, Elizabeth, et al.
Publicado: (2021)

Heterologous saRNA Prime, DNA Dual-Antigen Boost SARS-CoV-2 Vaccination Elicits Robust Cellular Immunogenicity and Cross-Variant Neutralizing Antibodies
por: Rice, Adrian, et al.
Publicado: (2022)

An ACE2 Triple Decoy that neutralizes SARS-CoV-2 shows enhanced affinity for virus variants
por: Tanaka, Shiho, et al.
Publicado: (2021)

Rapid identification of neutralizing antibodies against SARS-CoV-2 variants by mRNA display
por: Tanaka, Shiho, et al.
Publicado: (2022)

Identification of an immune gene expression signature associated with favorable clinical features in Treg-enriched patient tumor samples
por: Givechian, Kevin B., et al.
Publicado: (2018)

CAD/POLD2 gene expression is associated with poor overall survival and chemoresistance in bladder urothelial carcinoma
por: Givechian, Kevin B., et al.
Publicado: (2018)

Glycolytic expression in lower-grade glioma reveals an epigenetic association between IDH mutation status and PDL1/2 expression
por: Givechian, Kevin B, et al.
Publicado: (2020)

Learning subgroup-specific regulatory interactions and regulator independence with PARADIGM
por: Sedgewick, Andrew J., et al.
Publicado: (2013)

An immunogenic NSCLC microenvironment is associated with favorable survival in lung adenocarcinoma
por: Givechian, Kevin B., et al.
Publicado: (2019)

Multiple crystal structures of actin dimers and their implications for interactions in the actin filament
por: Sawaya, Michael R., et al.
Publicado: (2008)

Comprehensive genomic transcriptomic tumor-normal gene panel analysis for enhanced precision in patients with lung cancer
por: Rabizadeh, Shahrooz, et al.
Publicado: (2018)

Strategies for intranasal delivery of vaccines
por: Zaman, Mehfuz, et al.
Publicado: (2012)

Deep Learning Implicitly Handles Tissue Specific Phenomena to Predict Tumor DNA Accessibility and Immune Activity
por: Wnuk, Kamil, et al.
Publicado: (2019)

Identification and validation of expressed HLA-binding breast cancer neoepitopes for potential use in individualized cancer therapy
por: Reimann, Hannah, et al.
Publicado: (2021)

Single-cell sequencing and tumorigenesis: improved understanding of tumor evolution and metastasis
por: Ellsworth, Darrell L., et al.
Publicado: (2017)

Cytokines: The Future of Intranasal Vaccine Adjuvants
por: Thompson, Afton L., et al.
Publicado: (2011)

Vault Nanocapsules as Adjuvants Favor Cell-Mediated over Antibody-Mediated Immune Responses following Immunization of Mice
por: Kar, Upendra K., et al.
Publicado: (2012)

Intranasal COVID-19 vaccine: a modern vaccination approach
por: Shahnoor, Syeda, et al.
Publicado: (2023)

P19-47. Novel adenovirus type 5 vaccine platform induces cellular immunity against HIV-1 Gag, Pol, Nef despite the presence of Ad5 immunity
por: Gabitzsch, ES, et al.
Publicado: (2009)

Stable transplantation of human mitochondrial DNA by high-throughput, pressurized isolated mitochondrial delivery
por: Sercel, Alexander J, et al.
Publicado: (2021)

Advantages of Intranasal Vaccination and Considerations on Device Selection
por: Birkhoff, M., et al.
Publicado: (2009)

Correction: Identification of Androgen Receptor Splice Variants in the Pten Deficient Murine Prostate Cancer Model
por: Liang, Mengmeng, et al.
Publicado: (2016)

Identification of Androgen Receptor Splice Variants in the Pten Deficient Murine Prostate Cancer Model
por: Liang, Mengmeng, et al.
Publicado: (2015)

Pressure-Driven Mitochondrial Transfer Pipeline Generates Mammalian Cells of Desired Genetic Combinations and Fates
por: Patananan, Alexander N., et al.
Publicado: (2020)

A deep learning image-based intrinsic molecular subtype classifier of breast tumors reveals tumor heterogeneity that may affect survival
por: Jaber, Mustafa I., et al.
Publicado: (2020)

Intranasal COVID-19 vaccines: Is it a boon or bane?
por: Choudhary, Om Prakash, et al.
Publicado: (2021)

Intranasal COVID-19 vaccines: From bench to bed
por: Alu, Aqu, et al.
Publicado: (2022)

Potentiating Lung Mucosal Immunity Through Intranasal Vaccination
por: Nelson, Sean A., et al.
Publicado: (2021)

Peptidome Surveillance Across Evolving SARS-CoV-2 Lineages Reveals HLA Binding Conservation in Nucleocapsid Among Variants With Most Potential for T-Cell Epitope Loss in Spike
por: Wnuk, Kamil, et al.
Publicado: (2022)

Cellular Immune Responses to Nine Mycobacterium tuberculosis Vaccine Candidates following Intranasal Vaccination
por: Sable, Suraj B., et al.
Publicado: (2011)

Acceptability of intranasal live attenuated influenza vaccine, influenza knowledge and vaccine intent in The Gambia
por: Armitage, Edwin P., et al.
Publicado: (2018)

Investigating Prime-Pull Vaccination through a Combination of Parenteral Vaccination and Intranasal Boosting
por: Roces, Carla B., et al.
Publicado: (2019)

The Landscape of Targeted Immune Responses in the HIV-1 Vaccine Field
por: Safrit, Jeffrey T., et al.
Publicado: (2016)

Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADCC)–mediating agents with poly (ADP-ribose) polymerase (PARP) inhibition
por: Fenerty, Kathleen E., et al.
Publicado: (2018)

Correction to: Immunotherapy Utilizing the Combination of Natural Killer– and Antibody Dependent Cellular Cytotoxicity (ADCC)–Mediating Agents with Poly (ADP-ribose) polymerase (PARP) Inhibition
por: Fenerty, Kathleen E., et al.
Publicado: (2019)

Anatomical and Histological Factors Affecting Intranasal Drug and Vaccine Delivery
por: Gizurarson, Sveinbjörn
Publicado: (2012)

Intranasal Vaccination With Lipoproteins Confers Protection Against Pneumococcal Colonisation
por: Voß, Franziska, et al.
Publicado: (2018)

Broadly Neutralizing Antibodies for Influenza: Passive Immunotherapy and Intranasal Vaccination
por: Biswas, Mrityunjoy, et al.
Publicado: (2020)

Development and Optimization of Chitosan Nanoparticle-Based Intranasal Vaccine Carrier
por: Gao, Xiaoyi, et al.
Publicado: (2021)

Intranasal SARS-CoV-2 Vaccines: Indispensable and Inevitable
por: Adashi, Eli Y., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u5ij4d86i6ib7o58bm4j5rj06j